Chagas Disease
chagas_transmission_cycle.jpg

The second country to report human cases of tripanosomiasis americana or Chagas disease was El Salvador (Segovia 1913). In Honduras, the first human case was reported during the decade of the 60s (León-Gómez et al. 1960). Earlier, the natural infection by Trypanosoma cruzi had been reported in Didelphis marsupialis (Robertson 1931). Chagas disease is a priority problem for public health in Central America, specially in El Salvador, Guatemala, Honduras and Nicaragua. The infection prevalence estimated for the population of these four countries is of 7% (approximately 2 million people). Chronic cardiomyopathy is the most frequently observed manifestation. In Honduras 20% of chronic cardiopathies are chagasic and 36% of pacemakers implanted are for chagasic cardiomyopathy.

Excerpt from: Carlos Ponce. Elimination of the Vectorial Transmission of Chagas Disease in Central American Countries: Honduras. Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 94, Suppl. I: 417-418, 1999.

References:

Carlos Ponce. Elimination of the Vectorial Transmission of Chagas Disease in Central American Countries: Honduras. Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 94, Suppl. I: 417-418, 1999.

Elimination of the Vectorial Transmission of Chagas Disease in Central American Countries: Honduras [http://www.scielo.br/pdf/mioc/v94s1/7100.pdf ]

Henao-Martínez AF, Schwartz DA, Yang IV. Chagasic cardiomyopathy, from acute to chronic: is this mediated by host susceptibility factors? Trans R Soc Trop Med Hyg. 2012 Sep;106(9):521-7. doi: 10.1016/j.trstmh.2012.06.006. Epub 2012 Jul 21.
http://www.ncbi.nlm.nih.gov/pubmed/22819769

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License